A noted analyst has slashed his expectation for Apple stock by about 10% given what he sees to be slower iPhone upgrade rates ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Morgan Stanley maintains that India's long-term equity outlook is strong, despite recent market dips. Key factors include ...

Intel (NASDAQ:INTC) just sent its stock soaring after-hours – up more than 10% – all thanks to a big leadership shake-up. The company announced ...

After nearly doubling in value between Nov. 5 and Dec. 17 to hit $488 per share and give the electric vehicle maker a $1.6 ...

Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

Nifty IT in Wednesday's trade was the sole loser-trading in the red as recessionary fears in the US outweighed. At the last ...

A majority of investors believe Musk's political activity is hurting Tesla, a survey by Morgan Stanley found. Tesla shares jumped Wednesday as tech stock rallied, but remained on pace to decline for ...

On Coforge, the brokerage cut its target price to Rs 9,400 from Rs 11,500. It reduced its target on TCS to Rs 3,950 from Rs 4 ...

Investment bank Morgan Stanley cut its price target on Apple stock, citing a lack of compelling AI features to drive iPhone ...

Morgan Stanley analyst Josh Baer lowered the firm’s price target on Asana (ASAN) to $15 from $18 and keeps an Equal Weight rating on the ...

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.